Overview
Cerebral cortical dysplasia (also referred to as focal cortical dysplasia or cortical malformation) is a rare congenital brain malformation characterized by abnormal development of the cerebral cortex, the outer layer of the brain responsible for higher cognitive functions, motor control, and sensory processing. The condition arises from disrupted neuronal migration and organization during fetal brain development, leading to areas of abnormally structured cortical tissue. These malformations primarily affect the central nervous system and can vary widely in extent and location within the brain. The hallmark clinical feature of cerebral cortical dysplasia is epilepsy, which is often drug-resistant and may present in infancy or childhood. Seizures can be focal or generalized depending on the location and extent of the cortical abnormality. Additional symptoms may include intellectual disability, developmental delay, motor impairment, and speech or language difficulties. The severity of symptoms is highly variable and correlates with the size, location, and type of cortical malformation present. Diagnosis is typically established through brain magnetic resonance imaging (MRI), which can reveal characteristic abnormalities such as cortical thickening, blurring of the gray-white matter junction, and abnormal gyral patterns. Electroencephalography (EEG) is used to characterize seizure activity. Treatment primarily focuses on seizure management with antiepileptic medications. In cases of medically refractory epilepsy, surgical resection of the dysplastic cortical area may be considered and can be curative in selected patients. Supportive therapies including physical therapy, occupational therapy, and speech therapy are important components of comprehensive management. Genetic counseling may be offered, as some forms of cortical dysplasia have been associated with mutations in genes involved in the mTOR signaling pathway.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventChinese University of Hong Kong
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Cerebral cortical dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Cerebral cortical dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cerebral cortical dysplasia.
Community
No community posts yet. Be the first to share your experience with Cerebral cortical dysplasia.
Start the conversation →Latest news about Cerebral cortical dysplasia
Disease timeline:
New recruiting trial: Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
A new clinical trial is recruiting patients for Cerebral cortical dysplasia
New recruiting trial: Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)
A new clinical trial is recruiting patients for Cerebral cortical dysplasia
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cerebral cortical dysplasia
What is Cerebral cortical dysplasia?
Cerebral cortical dysplasia (also referred to as focal cortical dysplasia or cortical malformation) is a rare congenital brain malformation characterized by abnormal development of the cerebral cortex, the outer layer of the brain responsible for higher cognitive functions, motor control, and sensory processing. The condition arises from disrupted neuronal migration and organization during fetal brain development, leading to areas of abnormally structured cortical tissue. These malformations primarily affect the central nervous system and can vary widely in extent and location within the brain
Which specialists treat Cerebral cortical dysplasia?
21 specialists and care centers treating Cerebral cortical dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.